TBD
Type 1 and Type 2 Diabetes Nephropathy Study
The purpose of this study is to determine study drug effectiveness in the treatment of diabetic nephropathy.
To qualify to participate:
How to Participate
To participate, contact Jonathan Williams at (615) 875-9200 or e-mail at jonathan.m.williams@vanderbilt.edu
© 2010-2018. All Rights Reserved to Vanderbilt University. Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Version 2.18
Released April 5, 2018